drugset / Trial / NCT04963439
A Study of Two Macitentan Pediatric Formulations in Healthy Adult Participants
RandomizedCrossoverOpen-labelOther
Summary
The purpose of this study is to assess the rate and extent of absorption of macitentan following administration of a single oral dose of macitentan formulated as final market image (FMI) (test), compared to macitentan as the clinical service formulation (CSF) under fasted conditions in healthy adult participants.
Timeline
- Start
- 2021-07-08
- Primary completion
- 2021-09-12
- Completion
- 2021-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Macitentan | Other / unclassified | — | Oral |
Indications
No indication recorded.